SCHEMBL27679889

SCHEMBL27679889

O=c1[nH]cncc1-c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.64
MEN1 O00255 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C19 P33261 1/20 0.51
KMT2A Q03164 1/20 0.51
LMNA P02545 2/20 0.46
NPSR1 Q6W5P4 1/20 0.44
PARP1 P09874 1/20 0.44
DYRK1A Q13627 1/20 0.44
DYRK1B Q9Y463 1/20 0.44
CYP19A1 P11511 1/20 0.44
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
GAA P10253 1/20 0.43
GYS1 P13807 1/20 0.43
NOTUM Q6P988 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18799040 0.78 MAPT (1.00) MAPTCYP3A4LMNANPSR1CYP19A1
SCHEMBL5073672 0.73 HTR7 (0.46) MAPTMEN1KMT2ALMNAKDM4E
SCHEMBL6423919 0.72 CA1 (0.67) MAPTLMNACYP19A1KDM4EALDH1A1
SCHEMBL28198 0.72 CA1 (0.67) MAPTLMNACYP19A1KDM4EALDH1A1
SCHEMBL5072019 0.70 PSD (0.46) MAPTMEN1CYP3A4KMT2ALMNA
Water SCHEMBL28670631 0.70 CA1 (0.64) MAPTLMNAKDM4EALDH1A1GAA
SCHEMBL6780490 0.70 MAPT (0.49) MAPTCYP1A2CYP3A4LMNANPSR1
SCHEMBL3447074 0.69 MAPT (0.62) MAPTMEN1CYP3A4KMT2ALMNA
SCHEMBL527121 0.69 MEN1 (0.53) MAPTMEN1CYP1A2CYP3A4CYP2C19
SCHEMBL16472053 0.69 MEN1 (0.53) MAPTMEN1CYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1918133-A Alpha-4 integrin mediated cell adhesion inhibitors for the treatment or prevention of inflammatory diseases TANABE SEIYAKU CO (JP) 2007-02-21 CN disclosed